BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32447782)

  • 21. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.
    Belaud-Rotureau MA; Parrens M; Carrere N; Turmo M; Ferrer J; de Mascarel A; Dubus P; Merlio JP
    Hum Pathol; 2007 Feb; 38(2):365-72. PubMed ID: 17134735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Characteristics and Prognosis of MAF Deletion in Chinese Patients With Multiple Myeloma.
    Wang Y; Li Q; Xing S; Zhang H; Li D
    Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e545-e550. PubMed ID: 31262667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FGFR3 preferentially colocalizes with IGH in the interphase nucleus of multiple myeloma patient B-cells when FGFR3 is located outside of CT4.
    Martin LD; Harizanova J; Mai S; Belch AR; Pilarski LM
    Genes Chromosomes Cancer; 2016 Dec; 55(12):962-974. PubMed ID: 27509849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
    Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
    Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amplification of 1q21 and other abnormalities in multiple myeloma patients from a tertiary hospital in singapore.
    Lim AS; Krishnan S; Lim TH; See K; Ng YJ; Tan YM; Choo N; Lau LC; Tien SL; Ma J; Tan D
    Indian J Hematol Blood Transfus; 2014 Dec; 30(4):253-8. PubMed ID: 25435723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MYC amplification on double minute chromosomes in plasma cell leukemia with double IGH/CCND1 fusion genes.
    Yamamoto K; Yakushijin K; Ito M; Goto H; Higashime A; Kajimoto K; Hayashi Y; Matsuoka H; Minami H
    Cancer Genet; 2020 Apr; 242():35-40. PubMed ID: 32035866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 16q23/MAF Gene Deletion Is a Frequent Cytogenetic Abnormality in Multiple Myeloma Associated With IgH Deletion but Significantly Lower Incidence of High-Risk Translocations.
    Rana S; Sreedharanunni S; Panakkal V; Singh Sachdeva MU; Varma N; Malhotra P
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e398-e401. PubMed ID: 33309247
    [No Abstract]   [Full Text] [Related]  

  • 28. [Detection of Molecular Cytogenetic Aberrations by Fluorescence in Situ Hybridization in Different Bone Marrow Samples of Multiple Myeloma].
    Wang YF; Wang H; Xi LY; Liu Y; Dong F; Wang JJ; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1352-6. PubMed ID: 26524036
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Hui H; Fuller KA; Eresta Jaya L; Konishi Y; Ng TF; Frodsham R; Speight G; Yamada K; Clarke SE; Erber WN
    J Clin Pathol; 2023 Nov; 76(11):763-769. PubMed ID: 36113967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.
    Slovak ML; Bedell V; Pagel K; Chang KL; Smith D; Somlo G
    Cancer Genet Cytogenet; 2005 Apr; 158(2):99-109. PubMed ID: 15796956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplification of IGH/CCND1 fusion gene in a primary plasma cell leukemia case.
    Ishigaki T; Sasaki K; Watanabe K; Nakamura N; Toyota S; Kobayashi H; Tohda S
    Cancer Genet Cytogenet; 2010 Aug; 201(1):62-5. PubMed ID: 20633772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of MUM1/IRF4-IgH fusion in multiple myeloma.
    Yoshida S; Nakazawa N; Iida S; Hayami Y; Sato S; Wakita A; Shimizu S; Taniwaki M; Ueda R
    Leukemia; 1999 Nov; 13(11):1812-6. PubMed ID: 10557056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translocation of the IgH locus is nearly ubiquitous in multiple myeloma as detected by immuno-FISH.
    Boersma-Vreugdenhil GR; Peeters T; Bast BJ; Lokhorst HM
    Blood; 2003 Feb; 101(4):1653. PubMed ID: 12560243
    [No Abstract]   [Full Text] [Related]  

  • 34. Close relation between 14q32/IGH translocations and chromosome 13 abnormalities in multiple myeloma: a high incidence of 11q13/CCND1 and 16q23/MAF.
    Takimoto M; Ogawa K; Kato Y; Saito T; Suzuki T; Irei M; Shibuya Y; Suzuki Y; Kato M; Inoue Y; Takahashi M; Sugimori H; Miura I
    Int J Hematol; 2008 Apr; 87(3):260-5. PubMed ID: 18274833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytogenetic and molecular aberrations of multiple myeloma patients: a single-center study in Singapore.
    Lim AS; Lim TH; See KH; Ng YJ; Tan YM; Choo NS; Lim SX; Yee Y; Lau LC; Tien SL; Sathish K; Tan DC
    Chin Med J (Engl); 2013; 126(10):1872-7. PubMed ID: 23673102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics.
    Bink K; Haralambieva E; Kremer M; Ott G; Beham-Schmid C; de Leval L; Peh SC; Laeng HR; Jütting U; Hutzler P; Quintanilla-Martinez L; Fend F
    Haematologica; 2008 Apr; 93(4):623-6. PubMed ID: 18326524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of the Cytogenetic Aberrations in Multiple Myeloma by Using Microrray Comparative Genomic Hybridization].
    Wang YF; Wang H; Xi LY; Zhang ZH; Wang J; Dong F; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1389-1395. PubMed ID: 30295256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel fusion transcripts in multiple myeloma.
    Lin M; Lee PL; Chiu L; Chua C; Ban KHK; Lin AHF; Chan ZL; Chung TH; Yan B; Chng WJ
    J Clin Pathol; 2018 Aug; 71(8):708-712. PubMed ID: 29453220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
    Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
    Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FGFR3 amplification in the absence of IGH@-FGFR3 fusion t(4;14) in myeloma.
    Quintero-Rivera F; El-Sabbagh Badr R; Rao PN
    Cancer Genet Cytogenet; 2009 Nov; 195(1):92-3. PubMed ID: 19837276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.